Health economic evaluation of peritoneal dialysis based on cost-effectiveness in Japan: a preliminary study

References

• Lameire N, Van Biesen W, Vanholder R. The role of peritoneal dialysis as first modality in an integrative approach to patients with end-stage renal disease. Perit Dial Int. 2000;20(Suppl 2):S134–141.10911659
   PubMedGoogle Scholar
• Blake PG. Integrated end-stage renal disease care: the role of peritoneal dialysis. Nephrol Dial Transplant. 2001;16(Suppl 5):61–66. doi:10.1093/ndt/16.suppl_5.61
   PubMed Web of Science ®Google Scholar
• Takura T. Concept of applying health economics to dialysis therapy. J Jpn Soc Dialysis Ther. 2012;45(2):101–105. doi:10.4009/jsdt.45.101
   Google Scholar
• Treharne C, Liu FX, Arici M, Crowe L, Farooqui U. Peritoneal dialysis and in-centre haemodialysis: a cost-utility analysis from a UK payer perspective. Appl Health Econ Health Policy. 2014;12(4):409–420. doi:10.1007/s40258-014-0108-725017433
   PubMedGoogle Scholar
• McDonald SP, Marshall MR, Johnson DW, Polkinghorne KR. Relationship between dialysis modality and mortality. J Am Soc Nephrol. 2009;20(1):155–163. doi:10.1681/ASN.200812123319092128
   PubMed Web of Science ®Google Scholar
• Chang YT, Hwang JS, Hung SY, et al. Cost-effectiveness of hemodialysis and peritoneal dialysis: a national cohort study with 14 years follow-up and matched for comorbidities and propensity score. Sci Rep. 2016;27(6):30266. doi:10.1038/srep30266
   Web of Science ®Google Scholar
• Karopadi AN, Mason G, Rettore E, Ronco C. The role of economies of scale in the cost of dialysis across the world: a macroeconomic perspective. Nephrol Dial Transplant. 2014;29(4):885–892. doi:10.1093/ndt/gft52824516226
   PubMedGoogle Scholar
• Klarenbach S, Tonelli M, Pauly R, et al. Economic evaluation of frequent home nocturnal hemodialysis based on a randomized controlled trial. J Am Soc Nephrol. 2014;25(3):587–594. doi:10.1681/ASN.201304036024231665
   PubMedGoogle Scholar
• Howard K, Salkeld G, White S, et al. The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology (Carlton). 2009;14(1):123–132. doi:10.1111/nep.2009.14.issue-119207859
   PubMedGoogle Scholar
• Goodkin DA, Bragg-Gresham JL, Koenig KG, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States in the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003;14(12):3270–3277. doi:10.1097/01.asn.0000078024.50060.c614638926
   PubMed Web of Science ®Google Scholar
• The ethical guidelines for epidemiological research by the Japanese Government: Ministry of Education, Culture, Sports, Science and Technology Ministry of Health, Labour and Welfare; 2008 Available from: http://www.lifescience.mext.go.jp/files/pdf/n796_01.pdf. Accessed 1228, 2015.
   Google Scholar
• Asche CV. Applying Comparative Effectiveness Data to Medical Decision Making: Easily Accessible Overview of Comparative Effectiveness. 1st ed. Switzerland: ADIS; 2016:1–113.
   Google Scholar
• Melamed ML, Eustace JA, Plantinga LC, et al. Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study. Nephrol Dial Transplant. 2008;23(5):1650–1658. doi:10.1093/ndt/gfn21218065788
   PubMedGoogle Scholar
• De Boer IH, Gorodetskaya I, Young B, Hsu CY, Chertow GM. The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. J Am Soc Nephrol. 2002;13(11):2762–2769. doi:10.1097/01.ASN.0000034202.91413.EB12397047
   PubMedGoogle Scholar
• Fellström BC, Jardine AG, Schmieder RE, et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009;360(14):1395–1407. doi:10.1056/NEJMoa081017719332456
   PubMed Web of Science ®Google Scholar
• Wanner C, Krane V, März W, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353(3):238–248. doi:10.1056/NEJMoa04354516034009
   PubMed Web of Science ®Google Scholar
• Takura T, Nakanishi T, Kawanishi H, et al. Cost-effectiveness of maintenance hemodialysis in Japan. Ther Apher Dial. 2015;19(5):441–449. doi:10.1111/1744-9987.1231426387878
   PubMedGoogle Scholar
• Kim HJ, Park JT, Han SH, et al. The pattern of choosing dialysis modality and related mortality outcomes in Korea: a national population-based study. Korean J Intern Med. 2017;32(4):699–710. doi:10.3904/kjim.2017.14128651309
   PubMedGoogle Scholar
• Tamayo Isla RA, Ameh OI, Mapiye D, et al. Baseline predictors of mortality among predominantly rural-dwelling end-stage renal disease patients on chronic dialysis therapies in Limpopo, South Africa. PLoS One. 2016;11(6):e0156642. doi:10.1371/journal.pone.015664227300372
   PubMedGoogle Scholar
• Nesrallah GE, Li L, Suri RS. Comparative effectiveness of home dialysis therapies: a matched cohort study. Can J Kidney Health Dis. 2016;3:19. doi:10.1186/s40697-016-0105-x27006781
   PubMedGoogle Scholar
• Marshall MR, Polkinghorne KR, Kerr PG, Hawley CM, Agar JW, McDonald SP. Intensive hemodialysis and mortality risk in Australian and New Zealand populations. Am J Kidney Dis. 2016;67(4):617–628. doi:10.1053/j.ajkd.2015.09.02526561355
   PubMedGoogle Scholar
• Wang IK, Liang WM, Lin CL, et al. Impact of dialysis modality on the survival of patients with end-stage renal disease and prior stroke. Int Urol Nephrol. 2016;48(1):139–147. doi:10.1007/s11255-015-1157-z26560476
   PubMedGoogle Scholar
• Marshall MR, Walker RC, Polkinghorne KR, Lynn KL. Survival on home dialysis in New Zealand. PLoS One. 2014;9(5):e96847. doi:10.1371/journal.pone.009684724806458
   PubMed Web of Science ®Google Scholar
• Lee MJ, Kwon YE, Park KS, et al. Glycemic control modifies difference in mortality risk between hemodialysis and peritoneal dialysis in incident dialysis patients with diabetes results from a nationwide prospective cohort in Korea. Medicine (Baltimore). 2016;95(11):e3118. doi:10.1097/MD.000000000000486426986162
   PubMedGoogle Scholar
• Heaf JG, Wehberg S. Relative survival of peritoneal dialysis and haemodialysis patients: effect of cohort and mode of dialysis initiation. PLoS One. 2014;9(3):e90119. doi:10.1371/journal.pone.009011924614569
   PubMedGoogle Scholar
• Fan SL, Pile T, Punzalan S, Raftery MJ, Yaqoob MM. Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function. Kidney Int. 2008;73(2):200–206. doi:10.1038/sj.ki.500257417914351
   PubMedGoogle Scholar
• Szeto CC, Chow KM, Lam CW, et al. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products—a 1-year randomized control trial. Nephrol Dial Transplant. 2007;22(2):552–559. doi:10.1093/ndt/gfl55917005526
   PubMedGoogle Scholar
• Haag-Weber M, Krämer R, Haake R, et al. Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study. Nephrol Dial Transplant. 2010;25(7):2288–2296. doi:10.1093/ndt/gfq04420197284
   PubMed Web of Science ®Google Scholar
• Kim SG, Kim S, Hwang YH, et al. Could solutions low in glucose degradation products preserve residual renal function in incident peritoneal dialysis patients? A 1-year multicenter prospective randomized controlled trial (Balnet Study). Perit Dial Int. 2008;28(Suppl 3):S117–122.18552239
   PubMed Web of Science ®Google Scholar
• Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002;62(3):1046–1053. doi:10.1046/j.1523-1755.2002.00505.x12164889
   PubMed Web of Science ®Google Scholar
• Bajo MA, Priez-Lozano ML, Albar-Vizcaino P, et al. Low-GDP peritoneal dialysis solution (‘balance’) has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid. Nephrol Dial Transplant. 2011;26(1):282–291. doi:10.1093/ndt/gfq70920571097
   PubMedGoogle Scholar
• Ohkusa Y, Sugawara T. Research for willingness to pay for one QALY gain. Med Soc. 2006;16(2):157–165.
   Google Scholar
• McKie J, Richardson J. The rule of rescue. Soc Sci Med. 2003;56(12):2407–2419. doi:10.1016/S0277-9536(02)00244-712742604
   PubMed Web of Science ®Google Scholar
• Williams A. Intergenerational equity: an exploration of the ‘fair innings’ argument. Health Econ. 1997;6(2):117–132. doi:10.1002/(ISSN)1099-10509158965
   PubMed Web of Science ®Google Scholar